Conexeu Sciences, Inc. (CNXU)
3.10
-0.22
(-6.63%)
USD |
NASDAQ |
Oct 02, 16:00
3.14
+0.04
(+1.29%)
After-Hours: 20:00
Conexeu Sciences Total Liabilities (Quarterly) : 1.306M for July 31, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2026 | 1.306M |
| April 30, 2026 | 1.003M |
| October 31, 2025 | 0.336M |
| Date | Value |
|---|---|
| April 30, 2025 | |
| October 31, 2024 | 0.439M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| AbbVie, Inc. | 141.00B |
| Vericel Corp. | 132.82M |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Savara, Inc. | 48.48M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.156M |
| Shareholders Equity (Quarterly) | 5.850M |
| Debt to Equity Ratio | 0.0124 |
| Current Ratio | 5.310 |
| Net Debt Paydown Yield | 0.00% |